FDA Inspection
Vogelzang, Nicholas J., M.D.Vogelzang, Nicholas J., M.D. – FDA Inspection, Aug 18, 2009
Record Details
This FDA Inspection record concerns Vogelzang, Nicholas J., M.D., with an inspection on August 18, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Vogelzang, Nicholas J., M.D.
- Inspection Date
- August 18, 2009
- Product Type
- Drugs
View Company Profile
ID · 89bb3c5d-5c14-47f2-b39e-18e89f8bc698
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 612067
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 50.27(a)Consent form not approved/signed/dated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vogelzang, Nicholas J., M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 21, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 16, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Vogelzang, Nicholas J., M.D.
- FDA Inspection 1173738 - 2022-06-21
- FDA Inspection 1007909 - 2017-03-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.